key: cord-0297999-71hv4iyi
authors: Du, Ying; Hertoghs, Nina; Duffy, Fergal J.; Carnes, Jason; McDermott, Suzanne M.; Neal, Maxwell L.; Schwedhelm, Katharine V.; McElrath, M. Juliana; De Rosa, Stephen C.; Aitchison, John D.; Stuart, Kenneth D.
title: Systems analysis of immune responses to attenuated P. falciparum malaria sporozoite vaccination reveals excessive inflammatory signatures correlating with impaired immunity
date: 2021-08-25
journal: bioRxiv
DOI: 10.1101/2021.07.28.454252
sha: 5e3cbb8a4e15ac1059a6ee65063427a8a40d143d
doc_id: 297999
cord_uid: 71hv4iyi

Immunization with radiation-attenuated sporozoites (RAS) can confer sterilizing protection against malaria, although the mechanisms behind this protection are incompletely understood. We performed a systems biology analysis of samples from the Immunization by Mosquito with Radiation Attenuated Sporozoites IMRAS) trial, which comprised P. falciparum RAS-immunized (PfRAS), malaria-naive participants whose protection from malaria infection was subsequently assessed by controlled human malaria infection (CHMI). Blood samples collected after initial PfRAS immunization were analyzed to compare immune responses between protected and non-protected volunteers leveraging integrative analysis of whole blood RNA-seq, high parameter flow cytometry, and single cell CITEseq of PBMCs. This analysis revealed differences in early innate immune responses indicating divergent paths associated with protection. In particular, elevated levels of inflammatory responses early after the initial immunization were detrimental for the development of protective adaptive immunity. Specifically, non-classical monocytes and early type I interferon responses induced within 1 day of PfRAS vaccination correlated with impaired immunity. Non-protected individuals also showed an increase in Th2 polarized T cell responses whereas we observed a trend towards increased Th1 and T-bet+ CD8 T cell responses in protected individuals. Temporal differences in genes associated with natural killer cells suggest an important role in immune regulation by these cells. These findings give insight into the immune responses that confer protection against malaria and may guide further malaria vaccine development.

protected volunteers leveraging integrative analysis of whole blood RNA-seq, high parameter 23 flow cytometry, and single cell CITEseq of PBMCs. This analysis revealed differences in early 24 innate immune responses indicating divergent paths associated with protection. In particular, 25 elevated levels of inflammatory responses early after the initial immunization were detrimental 26 for the development of protective adaptive immunity. Specifically, non-classical monocytes and 27 early type I interferon responses induced within 1 day of PfRAS vaccination correlated with 28 impaired immunity. Non-protected individuals also showed an increase in Th2 polarized T cell 29 responses whereas we observed a trend towards increased Th1 and T-bet+ CD8 T cell responses 30 in protected individuals. Temporal differences in genes associated with natural killer cells suggest 31 an important role in immune regulation by these cells. These findings give insight into the 32 Introduction 37 Malaria is a devastating disease that results in over 200 million cases and hundreds of thousands 38 of deaths annually. Plasmodium falciparum causes the most serious disease and the most deaths, 39 especially in sub-Saharan Africa and primarily in children (Vekemans et al., 2021) . efforts to eliminate malaria have led to substantial reductions in malaria incidence but the 41 development of drug and insecticide resistance as well as other factors, including the current 42 COVID-19 pandemic, are a challenge to further progress (Vekemans et al., 2021; Weiss et al., 43 2021 ). An effective anti-malarial vaccine has been a long term goal which has proven challenging. 44 Currently, a single approved malaria vaccine exists, the RTS,S subunit vaccine, which elicited 28-45 33% protection in infants over a 4-year study period (RTSS Clinical Trials Partnership, 2015) . An (Coelho et al., 2017; Obeng-Adjei et al., 2015; Portugal et al., 2015, 55 2014). This mode of vaccination aims to elicit immunity against pre-erythrocytic parasite stages, 56 where the biomass of the parasites is low and the infection is asymptomatic. Currently, no 57 universal correlates of protection have been identified and the nature of protective immunity is 58 incompletely understood. Sterilizing immunity is likely to be complex and directed at multiple 59 antigens given that the P. falciparum genome encodes more than 5,300 unique proteins. 60 Available evidence indicates that antibodies against major surface proteins of infecting SPZs, e.g. 61 CSP and TRAP, contribute to protection (Ishizuka et al., 2016; Seder et al., 2013) . Animal models 62 have indicated that liver-resident CD8 T cell responses are important for protection, which is 63 inherently challenging to study in humans, as the human liver is not readily accessible for 64 sampling and a very small fraction of its cells get infected (Fernandez-Ruiz et al., 2016b; Trieu et 65 al., 2011) . It is imperative to identify correlates of protection in humans that can aid the 66 improvement of the current vaccines and development of vaccine candidates. To this end, human 67 vaccination and challenge trials with attenuated PfSPZs provide an opportunity to elucidate 68 immune responses that are associated with pre-erythrocytic protection. 69 70 In this study, we applied a systems immunology approach to identify correlates of protection that 71 are identifiable up to 28 days after initial vaccination in malaria naïve human trial subjects that 72 participated in the Immunization by Mosquito with Radiation Attenuated Sporozoites (IMRAS) 73 trial (Hickey et al., 2020) . Participants were immunized by PfRAS delivered by mosquito bite with 74 efficacy assessed by CHMI. Five total immunizations were delivered, spaced 4 to 5 weeks apart. 75 The trial was designed with a suboptimal vaccine dose regime to elicit approximately 50% vaccine 76 efficacy to facilitate comparison between protected (P) and non-protected (NP) subjects. Of 77 particular interest in the IMRAS trial is the prime vaccination. IMRAS participants are malaria 78 unexposed, and the initial PfRAS vaccination represents the first time their immune system has 79 been exposed to P. falciparum sporozoites. We hypothesized that the earliest immune resposnes 

The IMRAS cohort analyzed consisted of eleven malaria-naïve adults immunized with five doses 96 of approximately 200 bites from PfRAS NF54 infected mosquitos (Hickey et al., 2020) . The first 97 four doses were given four weeks apart and the final dose was administered five weeks after the 98 fourth. Protection was tested by controlled human malaria infection (CHMI) three weeks after 99 the final vaccination ( Fig. S1 A) . Six of the eleven immunized participants were protected, i.e. zero 100 parasitemia after CHMI. Of the five non-protected subjects one developed parasitemia on day 9 101 after CHMI and four did so on day 13 after CHMI ( Fig. S1 B) . There was no significant correlation 102 between the number of PfRAS infectious mosquito bites received and protection status among 103 true-immunized subjects (Fig. S1 C) .

PfSPZ vaccination induced broad transcriptome responses 106 Whole blood transcriptome profiling was performed on all eleven immunized IMRAS participants 107 at 6 timepoints after the initial PfRAS vaccination. We examined transcriptional changes between 108 adjacent timepoints, which we refer to as time "intervals", namely between days 0-1, 1-3, 3-7, 7-109 14, and 14-28 after immunization. We conducted linear mixed-effects regression modeling 110 analysis (LMER) of the responses to identify significantly responsive genes over all subjects and 111 those that differed between P and NP at each interval (FDR < 0.2 & p < 0.05; see Materials and 112 Methods). 90% confidence intervals (CIs) were calculated around model coefficients to label 113 genes as either increased or decreased if the CI was entirely above or below 0, respectively (Fig. 114 1A). Many significantly responsive genes were observed after the first PfSPZ vaccination; 8170 115 genes had increased or decreased expression responses over at least at one interval accross all 116 immunized subjects and approximately 10% of these differed significantly between P and NP 117 subjects (Fig. 1A ).

The association between vaccine induced gene responses and specific cell populations and 120 immunological processes was determined by testing whether pre-defined coherent blood 121 transcription module sets (BTMs) (Chaussabel et al., 2008a; Li et al., 2014a; Liberzon et al., 2015) 122 showed enrichment for significantly responsive genes (hypergeometric p < 0.1). We identified 123 122 BTMs significantly enriched in response genes in at least one time interval. Hierarchical 124 clustering of enriched BTM hypergeometric effect sizes at each interval revealed discrete time-125 dependent response patterns among the immunized subjects ( Fig. 1 B) . BTMs increased during 126 the first day after vaccination were associated broadly with immunity and inflammation, 127 including TLR sensing; antigen processing; interferon and inflammation; monocytes and 137 To further explore reponse dynamics of protection-associated genes, we performed 138 unsupervised clustering of the responses over time of the 1394 genes that were differentially 139 expressed between P and NP (FDR < 1/3 & p < 0.05, Fig.2 A; Materials and Methods). Hierarchical 140 clustering was performed separately for P and NP subjects to illustrate the response differences 141 between these two groups and to identify sets of genes with coherent response profiles over 142 time following PfSPZ immunization ( Fig. 2 A,C) . Immune functions and molecular mechanisms 143 associated with these clusters were identified by the hypergeometric enrichment test using BTMs 144 and by Ingenuity Pathway Analysis (IPA) (see Materials and Methods) (Fig. 2 B,D, Fig. S4 ). We 145 identified four major gene clusters for P subjects (P_1, P_2, P_3, P_4) and five for NP subjects 146 (NP_1, NP_2, NP_3, NP_4, NP_5). The patterns in which these 1394 genes changed over time 147 differed between P and NP, leading to substantial differences in gene composition of most of the 148 major P and NP clusters ( Fig.2 A,C,E). A total of 39 signficantly enriched BTMs and 159 significant 149 IPA pathways were identified between P and NP (Table S1 ). 150 151 Most gene clusters from both P and NP were strongly enriched for cell cycle-associated BTMs 152 ( Fig.2 B,D ). An important exception was P_1 and NP_1, both were associated primarily with 153 various immune response modules including many type I IFN-associated modules. These two 154 gene clusters have the largest total numbers of genes and associated BTMs. In total, P_1 and 155 NP_1 have 317 genes in common (hypergeometric p = 4.2e-17) (Fig. 2 E) , although numbers of 156 enriched modules and gene expression dynamics are distinct ( Fig. S2 A-C). Expression of most 157 genes in these clusters was increased over the interval D0-1, with higher response magnitude in 158 NP_1 (Fig. S2 C) . Consistent with strong enrichment of type I IFN associated modules in P and NP-159 associated cluster 1, we observed that IFN-stimulated genes (ISGs) were strongly increased 160 overall in NP compared with P and NP by day 1 after the first vaccination ( Fig.2 F, Mann Whitney 161 U test, P < NP, p < 2.2e-16) (Kazmin et al., 2017) . Furthermore, we observed significantly 162 increased expression of genes related to sensing through Pattern Recognition Receptors (PRR) in 163 NP participants by day 1, for both MyD88 dependent and independent pathways ( Fig. S3 A-C). 164 Altogether, these patterns indicate that overall innate sensing and inflammatory responses were 165 highly elevated in NP compared to P subjects, strongly suggesting that they negatively affected 166 the induction of adaptive immunity against SPZ challenge.

Gene set enrichment analysis identified early inflammation as correlate of impaired immunity 168 To more broadly explore immunological processes and cell types associated with protection we 169 performed gene set enrichment analysis (GSEA) separately for P and NP subjects at each time NP. BTMs in cluster 2 were generally associated with cell cycle and division. These BTMs were 184 downregulated over day 0-1 and day 7-14 and upregulated from day 3-7 in both P and NP. 185 Notably, most of these BTMs were activated in NP but not in P from day 3-7. Cluster 3 was the 186 most heterogeneous cluster in terms of composition and time dynamics, and included NK cell, 187 plasma cell and trancriptional regulatory BTMs among others. These modules tended to be 188 increased at early time intervals, before decreasing at day 7-14 and day 14-28. Notably, NK BTMs 189 were upregulated in P over day 0-1; however, their activation occurred late in NP over day 1-3 190 and day 3-7. Cluster 4 primarily represented innate inflammation, interferon, monocytes, We generated heatmaps of expression changes by averaging expression of genes from significant 212 cell-type associated BTMs identified by the GSEA analysis ( Fig. 4 A,B, Fig. S6 A-G). Monocytes, 213 DCs, neutrophils and platelet-associated responses were highly increased in NP over day 0-1, 214 indicating strong innate immune responses in NP that were absent or significantly lower in P 215 subjects ( Fig. 4 A To validate this whole blood transcriptional analysis, we applied high parameter flow cytometry 225 to characterize PBMCs isolated from immunized individuals after the first immunization. This was 226 done at overlapping time points with the whole blood transcriptional analyses, although we 227 lacked matching PBMC samples for the 1 day and 28 days post immunization timepoints (Table   228 S2, Fig.5 A-G) . We assessed whether transcriptional responses associated with specific cell types 229 were correlated with flow cytometry derived counts of the appropriate populations. vaccination studies to be correlated with impaired immunity (George et al., 2018; Mitchell et al., 235 2012). We also observed increased numbers of ILT3+ monocytes, associated with IFN exposure 236 (Jensen et al., 2010; Waschbisch et al., 2014) , after the first vaccination ( Fig.5 A, p = 0.0004). 237 Furthermore, by applying a previously identified transcriptional signature of macrophage 238 polarization (Becker et al., 2015) , we observed that responses associated with classically 239 activated macrophages were specifically increased in NP between day 0-1, but no change was 240 observed for alternatively activated macrophage responses (Fig S6 H,I) . We compared the 241 abundance and activation status of several DC subsets between P and NP subjects and found 242 several trends that were consistent with RNA-seq results, albeit not statistically significant (Fig. 5 243 E). We observed a subtle increase in plasmacytoid DCs, and overall increased CD11c+ DC numbers 244 3 days after the first immunization in NP compared to P subjects (Fig. 5 B) . Interestingly, the 245 proportion of "mature" CD1c+ DCs expressing CD86 was higher in P than NP subjects whereas 246 CD86 expressing CD11c+ DCs that lack CD1c or CD141 expression, and non-activated CD1c DCs 247 were enriched in NP subjects. These findings suggest that CD11c+ DCs, non-activated CD1c+ DCs 248 and non-classical monocytes contribute to the transcriptional signature in NP subjects where we 249 observed an increase in DC and monocyte-associated genes ( Fig.5 B, Fig. 4 5C ). In addition, we found a trend of higher circulating numbers of CD8 T cells and T-bet 254 expressing CD8 T cells in P subjects. In CD8 T cells, T-bet is an important transcription factor that 255 is involved in memory cell formation (Sullivan et al., 2003) . These data suggest that differences 256 in innate responses contributed to impaired protective immunity by skewing the CD4 T cells 257 toward a type 2 phenotype, and protective responses are hallmarked by Th1 and CD8 T cell 258 responses. The abundance of the NK cells in general, and CD38 expressing NK cells matched the 259 transcriptome responses in which NK-associated gene increases peaked at day 1-3 in P subjects 260 and day 7 in NP subjects (Fig. 5D ). However CD8-expressing NK cells subsets did not show any 261 early peak in P participants. Notably, CD8+ NK cells lacking FcRγ were more abundant in NP 262 subjects across all measured timepoints (Hart et al., 2019; Hwang et al., 2012; McKinney et al., 263 2021; Zambello et al., 2020) . 264 265 To quantify the relationships between the transcriptional and cytometric data, we performed 266 correlation analysis of temporal changes of BTMs and cell subsets from manually gated flow 267 cytometry data (Fig. 6 A) . These analyses showed that transcriptional activation of the innate (Table S3) . 286 We obtained single cell RNA seq gene expression and surface protein marker profile data from a 287 total of 12,442 cells. Mapping of these cells to a previously defined multimodal cell atlas based 288 on reference clusters identified 29 cell types in the merged samples (Fig. 7 A) (Hao et al., 2021) . 289 We then derived transcriptional cell-type associated signatures using genes highly expressed in 290 CITEseq-identified cell types in our samples, and applied these signatures in GSEA analysis of the 291 whole blood RNA-seq data (Fig. 7 B) . Consistent with previous BTM-based GSEA analyses, GSEA 292 with our CITEseq signatures indicated that CD14+ and CD16+ monocyte subsets were highly 293 activated on day 1 in NP subjects. By contrast, genes associated with NK cells were highly 294 activated on day 1 in P subjects, whereas the activation continued on day 3 in NP subjects (Fig. 7 295 B,C). Finally, comprehensive correlation analysis was performed to examine the relationship 296 between cell subsets predicted by CITEseq and cell-specific BTMs identified in our previous GSEA 297 (Fig. 3, Fig. 4) . The high correlation between cell-specific BTMs and corresponding cell types 298 identified in CITEseq data demonstrates that the cell subsets identified by both approaches are 299 consistent (Fig. 7 D) and supports our interpretation of these responses. Thus, integration of 300 whole blood RNA-seq, high parameter flow cytometry and scRNA-seq of individuals after initial 301 PfRAS vaccination revealed a consistent picture where inflammatory transcripts and non-classical 302 monocytes, and Th2 signalling are specifically increased in NP individuals in the first day after 303 PfRAS vaccination while P individuals are marked by increased early NK-cell and Th1 signalling. cytokines suppressed development of responses that protect against CHMI (Kim and Kim, 2018) . 342 We also observed a trend towards higher numbers of Th1 and CD8 T cells in P vs NP subjects at 343 early timepoints, suggesting that Th1 responses contribute to PfRAS vaccination-induced 344 immunity. This is consistent with studies in animal models which concluded that sterilizing 345 protection involves Th1 cells which secrete IFNγ and, in co-ordination with with macrophages 346 and liver resident cytotoxic CD8 T cells, eliminate intracellular pathogens (Cockburn et (Doolan and Hoffman, 2000) . Infection studies in animals have shown that malaria 377 infected hepatocytes produce type I IFN, and IFNγ-secreting NK and NKT cells are recruited as 378 liver stage parasites are eliminated (Miller et al., 2014) . However, type I IFN responses are also 379 detrimental to long term immunity against infection (Liehl et al., 2015 (Liehl et al., , 2014 Miller et al., 2014; 380 Minkah et al., 2019) . Caspase-mediated cell death of infected hepatocytes is required for the 381 uptake and presentation of malaria antigens by innate phagocytic cells (Kaushansky et al., 2013; 382 Kurup et al., 2019; Marques-Da-Silva et al., 2021) but type I IFN can inhibit caspase activity and 383 inflammasome activation thus potentially inhibiting the presentation of malaria antigens (Guarda 384 et al., 2011; Veeranki et al., 2011) . IFNAR signaling during malaria liver infection may also impair 385 the induction of Th1 and CD8 T cell responses and enhance exhaustion of liver resident CD8 T 386 cells (Haque et al., 2014; Minkah et al., 2019; Nagai et al., 2003) . In addition, type I IFN can 387 hamper protective immunity via inhibition of IFNγ responsiveness by monocytes and 388 macrophages that in turn can limit the induction of Th1 responses (de Paus et al., 2013; 389 Rayamajhi et al., 2010) . Overall IFNγ is an important mediator in anti-malarial immunity with a 390 variety of downstream effects besides macrophage activation (King and Lamb, 2015) . We did not 391 find that the best known and potent producers of large quantities of type I IFN, namely 392 plasmacytoid DCs (pDCs), had significantly higher levels of in NP subjects; however, other innate 393 cells, e.g. neutrophils, monocytes and DCs can secrete type I IFN (Ali et al., 2019; Rocha et al., 394 2015) . 395 396 NK cell-associated transcriptome responses (Figs 3A and 4A) and relative changes in NK cell 397 subset numbers (Fig 6B) occur earlier in P than in NP subjects, which may indicate that they 398 contribute to the development of immunity, perhaps via the balance between Th1 and Th2 399 responses. NK cells can be activated by neutrophils as well as inflammatory monocytes through 400 type I IFN Lee et al., 2017) and they can have diverse functions. 401 They can act as immune regulators that enhance or suppress adaptive responses and they can 402 be innate effectors that rapidly respond to and eliminate infected or tumor cells (Schuster et al., 403 2016; Vivier et al., 2008) . IFNy secretion by NK cells can support DC-mediated Th1 induction 404 (Schuster et al., 2016; Zhao et al., 2020) , analogous to that we observed in P subjects, but NK cells 405 can also limit adaptive responses by suppressing DCs, CD4 T cells and B cells and thus variably 406 impact outcomes (Hayakawa et al., 2004; Piccioli et al., 2002; Zhang et al., 2013; Zhao et al., 407 2020). Furthermore, NK cells can reduce inflammation, e.g. as with COVID-19 related immune 408 pathology (Li et al., 2020; Mehta et al., 2020; van Eeden et al., 2020; Zheng et al., 2020) . Thus, 409 the early NK responses in P subjects may support the priming of a Th1 polarized response and 410 inhibit inflammation that in NP subjects primes a Th2 response. Interestingly, we identified a 411 novel NK cell subset that expressed CD8 and lacked FcRγ expression and which is more abundant 412 in NP subjects in the day 3-7 interval (Fig. 5D) . FcRγ-lacking NKs have previously been associated 413 with an adaptive phenotype that is protective against seasonal malaria infection (Hart et al., 414 2019). Further investigations into this phenotype could elucidate its functionality. That this study was performed on blood samples, despite decisive immune events occuring in the 433 liver, which is essentially experimentally inaccessible, limited us to indirect analysis of phenotypic 434 differences between the P and NP subjects rather than functional assays. The sample size is 435 relatively small, which reduced our sensitivity to discover more subtle changes associated with 436 protection, especially given natural variation in the participants. However, the detection of 437 robust correlates of protection despite the low numbers increases our confidence that we have 438 identified meaningful responses. These findings can inform further studies to extend the 439 understanding of protective immunity and its development. In addition, multiple factors may 440 have influenced the differences that between P and NP subjects that we described here, and 441 which influenced protection. These include intrinsic differences between subjects, such as HLA 442 type and other genetic differences as well as baseline immune status at the time of immunization. Quality control and processing of RNA-Seq data 470 RNA-seq data were processed as previously described (Thompson et al., 2017) . Read pairs were 471 adjusted to set base calls with phred scores < 5 to 'N'. Read pairs for which either end had fewer 472 than 30 unambiguous base calls were removed, a method that indirectly removes pairs 473 containing mostly adaptor sequences. Read pairs were aligned to the human genome (hg19) 474 using STAR (v2.3.1d) (Dobin et al., 2013) . Gene count tables were generated using htseq (v. 0.6.0) 475 with the intersection-strict setting on and Ensembl gene annotations (GRCh37.74) used to link 476 genomic locations to gene identifiers (Anders et al., 2015) . Log2-transformed TMM-normalized 477 counts-per-million (CPM) expression matrices were computed using the cpm function of the 478 edgeR package (McCarthy et al., 2012) . Batch correction for sequencer model (Hiseq2000vs 479 BGI5000) was performed on log2-transformed counts using linear mixed-effects models with 480 normally distributed errors and an unstructured covariance matrix. Mixed-effects models were 481 fit using the R (https://www.r-project.org/) Lme4 package (Bates et al., 2015) . The following 482 formula was used: Gene set enrichment analysis (GSEA) 540 GSEA was performed for each vaccination time interval using the R fgsea package (Korotkevich 541 et al., 2016; Mootha et al., 2003; Subramanian et al., 2005) with 500 permutations and whole 542 blood transcriptional modules (Chaussabel et al., 2008b; Li et al., 2014b; Subramanian et al., 543 2005; Tran et al., 2019) . Genes were ranked by average fold change across each time interval 544 (day 1 to day 0, day 3 to day 1, day 7 to day 3, day 14 to day 7, day 28 to day 14) separately for 545 samples from P and NP subjects. Normalized enrichment scores (NES) of non-significant modules 546 (FDR-adjusted P-value > 0.05) were set to 0. was determined by the "elbow" method (Thorndike, 1953 Mair and Prlic, 2018) . The cells were then acquired using a BD FACSymphony flow cytometer. The 572 data were analyzed, and cellular populations gated and quantified using FlowJo Software (version 573 9.6.6). The percentage contribution of each manually gated cell subset was calculated using the 574 counts of each defined cell subset divided by the total single live cells from that sample. Pearson 575 correlation coefficients were calculated between cell type proportion changes and BTM mean 576 expression level changes per-time interval for P an NP subjects separately. Single-cell RNA seq processing and analysis 609 Raw count data were filtered to remove cells where 1) a mitochondrial RNA fraction greater than 610 7.5% of total RNA counts per cell, and 2) less than 200 or greater than 2500 genes were detected. 611 The resultant count matrix was used to create a Seurat (v4.0.1) (Hao et al., 2021) object. Filtered 612 read counts were normalized, scaled, and corrected for mitochondrial and rRNA read 613 percentages with the SCTransform function. The ADT matrix was normalized per feature using 614 center log normalization. Cell types in each sample were annotated by mapping to the annotated 615 reference PBMC dataset provided in the Seurat v4 Azimuth workflow. Briefly, anchors between 616 the query and reference datasets were identified using a precomputed supervised PCA on the 617 reference dataset. Next, cell type labels from the reference dataset, as well as imputations of all 618 measured protein markers, were transferred to each cell of the query datasets through the 619 previously identified anchors. The query datasets were then merged and projected onto the 620 UMAP structure of the reference. The genes expressed in each specific cell cluster were identified 621 using the FindAllMarkers function from the Seurat4 package and filtered to include those with 622 average log2 fold changes greater than 1 and FDR-adjusted P-values less than 0.05. 

Sources of type I interferons 639 in infectious immunity: Plasmacytoid dendritic cells not always in the driver's seat. Front 640 Immunol

HTSeq-A Python framework to work with high-throughput 642 sequencing data

Fitting linear mixed-effects models using 644 lme4

Polarization Signatures and have Potential Applications for Clinical Health and Disease

A modular analysis framework for 653 blood genomics studies: application to systemic lupus erythematosus

A Modular Analysis Framework for 659

In vivo imaging of CD8+ T cell-mediated elimination of malaria 663 liver stages

Advances in malaria vaccine development: 665 Report from the 2017 malaria vaccine symposiumNpj Vaccines

Human dendritic cell subsets: an update

The defensive alliance between neutrophils and NK cells as a 670 novel arm of innate immunity

Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β

STAR: Ultrafast universal RNA-seq aligner

The Complexity of Protective Immunity Against Liver-Stage 678

Plasmodium falciparum malaria by PfSPZ Vaccine

Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense against Malaria Liver-Stage 692

Supplemental Information Liver-Resident Memory CD8 + T Cells Form a Front-Line 698

Defense against Malaria Liver-Stage Infection

Circulating 701 inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-702 infected participants

Integrated analysis of multimodal single-cell data

Type I IFN signaling in 713 CD8-DCs impairs Th1-dependent malaria immunity

Adaptive NK cells in people 717 exposed to Plasmodium falciparum correlate with protection from malaria

NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell 721 Vaccination Efficacy

Flow Cytometry Panel to Detect and Characterize Human NK Cells and Other Innate 724

IMRAS-A clinical trial of mosquito-bite 731 immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of 732 immunization parameters on protective efficacy and generation of a repository of 733 immunologic reagents

735 Identification of human NK cells that are deficient for signaling adaptor FcRγ and 736 specialized for antibody-dependent immune functions

Protection 755 against malaria at 1 year and immune correlates following PfSPZ vaccination

Immunoglobulin-like 758 transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during 759 multiple sclerosis relapses and is induced by interferon β2-1b

Malaria parasite liver stages render host hepatocytes susceptible to mitochondria-763 initiated apoptosis

Systems analysis of protective immune 767 responses to RTS,S malaria vaccination in humans

Fundamental role of dendritic cells in inducing Th2 responses

Interferon-γ: The Jekyll and Hyde of Malaria

Fast gene set 774 enrichment analysis

Monocyte-Derived CD11c + Cells Acquire Plasmodium from

Hepatocytes to Prime CD8 T Cell Immunity to Liver-Stage Malaria

Antigen-Specific Inhibition of CD8 + T 780

Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen 781

Inflammatory monocytes require 784 type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral 785 infection

Immune dysfunction 787 leads to mortality and organ injury in patients with COVID-19 in China

COVID-19 study

Systems biological approaches to 790 measure and understand vaccine immunity in humans

Molecular signatures 795 of antibody responses derived from a systems biology study of five human vaccines

Molecular signatures of 800 antibody responses derived from a systems biology study of five human vaccines

The Molecular 803 Signatures Database (MSigDB) hallmark gene set collection

Innate immunity induced by Plasmodium liver infection inhibits 807 malaria reinfections

Host-cell sensors for Plasmodium activate innate immunity 812 against liver-stage infection

OMIP-044: 28-color immunophenotyping of the human dendritic cell 814 compartment

Neutrophils in the activation and 816 regulation of innate and adaptive immunity

Caspase-1 in hepatocytes limits control of malaria in the liver

Differential expression analysis of multifactor RNA-Seq 822 experiments with respect to biological variation

A CD8+ NK cell transcriptomic signature associated with clinical outcome 826 in relapsing remitting multiple sclerosis

Type I interferons in infectious 829 disease

Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in 833 the hepatic sinusoids

COVID-19: consider 835 cytokine storm syndromes and immunosuppression

Immune Responses against Malaria Parasite Liver Stages

Innate immunity limits protective adaptive immune responses against pre-erythrocytic 842 malaria parasites

Suppression of Vaccine Immunity by Inflammatory 844

PGC-1α-responsive 848 genes involved in oxidative phosphorylation are coordinately downregulated in human 849 diabetes

Timing of

Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has 852

Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-853

Family Cytokines and IL-18 in Naive Th Cell Differentiation

Circulating Th1-Cell-type Tfh Cells 857 that Exhibit Impaired B Cell Help Are Preferentially Activated during Acute Malaria in 858

Basophils are 861 required for the induction of Th2 immunity to haptens and peptide antigens

CD4 T-cell subsets in malaria: Th1/Th2 revisited. Front 864 Immunol

CD11c depletion severely disrupts 867 Th2 induction and development in vivo

Contact-dependent stimulation and 870 inhibition of dendritic cells by natural killer cells

Chemoprophylaxis 874 with sporozoite immunization in P. knowlesi rhesus monkeys confers protection and elicits 875 sporozoite-specific memory T cells in the liver

A subset of neutrophils in human systemic inflammation inhibits T 879 cell responses through Mac-1

Exposure-Dependent Control of Malaria-Induced Inflammation in 883

Malaria-associated atypical memory B cells exhibit markedly reduced 887 B cell receptor signaling and effector function

Induction of IFN-αβ enables 889

Listeria monocytogenes to suppress macrophage activation by IFN-γ

A CD4+ T-cell immune response to a conserved 894 epitope in the circumsporozoite protein correlates with protection from natural 895

Plasmodium falciparum infection and disease

Neutrophils and Low-Density Granulocytes Are Associated with Tissue Damage in Malaria

Platelets 902 Fuel the Inflammasome Activation of Innate Immune Cells

Efficacy and safety of RTS,S/AS01 malaria vaccine with or 905 without a booster dose in infants and children in Africa: Final results of a phase 3, 906 individually randomised, controlled trial

Natural Regulators": NK cells as 909 modulators of T cell immunity

Protection against malaria by 916 intravenous immunization with a nonreplicating sporozoite vaccine

Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response 920 through the Recruitment of Myeloid Suppressor Cells

Gene set enrichment analysis: A 923 knowledge-based approach for interpreting genome-wide expression profiles

Antigen-driven effector 926

CD8 T cell function regulated by T-bet

The T helper type 2 response to cysteine proteases requires dendritic 930 cell-basophil cooperation via ROS-mediated signaling

Host blood RNA signatures predict the 935 outcome of tuberculosis treatment

Who belongs in the family?

Distinct dendritic cell subsets actively induce Th2 polarization

Whole-blood transcriptomic signatures induced 943 during immunization by chloroquine prophylaxis and Plasmodium falciparum sporozoites

Sterile protective immunity to malaria is associated with a panel of novel P. 947 falciparum antigens

The chemokine receptor CXCR6 is 949 required for the maintenance of liver memory CD8 + T cells specific for infectious 950 pathogens

Natural killer cell dysfunction and its role 952 in covid-19

IFI16 protein mediates the anti-954 inflammatory actions of the type-I interferons through suppression of activation of 955 caspase-1 by inflammasomes

Meeting report: WHO 957 consultation on malaria vaccine development

Functions of natural killer cells

Interferon beta and vitamin D synergize to induce immunoregulatory receptors on 963 peripheral blood monocytes of multiple sclerosis patients

COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a 969 geospatial modelling analysis

Molecular signature of CD8+ T cell exhaustion during chronic 973 viral infection

NK cells and CD38: Implication for 975 (Immuno)Therapy in Plasma Cell Dyscrasias. Cells

Neutrophil-mediated T-cell suppression in influenza: Novel finding raising 977 additional questions

Follicular helper T 979 cells: New insights into mechanisms of autoimmune diseases

NK 981 cells modulate T cell responses via interaction with dendritic cells in Chlamydophila 982 pneumoniae infection

Functional exhaustion of 984 antiviral lymphocytes in COVID-19 patients

T-cells (E), B cells (F), NK cells (G), classically activated 1123 macrophages (H) and alternatively activated macrophages (I). Expression values were z-score 1124

BTMs. Asterisks represent significant differences in expression between P and NP for a time 1036 interval (Mann Whitney U test. ****: p < 0.0001; ***: p < 0.001; **: p < 0.01; *: p < 0.05). BTM 1037 clusters derived from hierarchical clustering are indicated by numbers to the right of the 1038 heatmap. Black sidebar on the left represents BTMs also enriched in unsupervised clusters of 1039 protection associated genes in P and NP subjects (Fig 1 B)